CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...
Discover the top 15 developments in cardiology for 2024, including new technologies, acquisitions, and partnerships, that will shape the industry in 2025.
West Yorkshire has begun the Heath and Care Partnership and has rolled out an app to support patients with cardiovascular disease health screening supported by app-based technology.